Dorsal Nasal Artery and Dermal Filler Safety

Critical Safety Recommendations

The American Academy of Dermatology recommends using strict intradermal injection technique with 30-gauge needles at shallow angles, creating visible papules to confirm superficial placement and avoid the dorsal nasal artery, which connects directly to the ophthalmic artery and poses catastrophic blindness risk 1

Inject exclusively in the intradermal layer using 30-gauge, 4mm needles with the bevel facing upward, as recommended by the American Academy of Dermatology, to confirm dermal placement and avoid the hypodermis where the dorsal nasal artery resides 1, 2

Aspirate before every single injection to detect intravascular needle placement, as recommended by the American Academy of Dermatology, to minimize the risk of vascular compromise 3, 4
Use incremental small-volume injections (maximum 0.2-0.5 mL per site) rather than boluses to allow early complication detection, as recommended by the American Academy of Dermatology, to reduce the risk of intravascular injection 3, 4
Inject in retrograde fashion while withdrawing the needle to minimize intravascular injection risk, as recommended by the American Academy of Dermatology, to reduce the risk of vascular compromise 4

For patients seeking nasal refinement without significant volumization, consider autologous platelet concentrates (APCs) instead of hyaluronic acid fillers, as recommended by the American Academy of Dermatology, to provide skin quality improvement and fine line reduction with potentially lower vascular catastrophe risk 1, 2, 4

Never inject large volumes rapidly, as recommended by the American Academy of Dermatology, to increase intravascular pressure and embolization risk even if you're not directly in the vessel 3, 4